Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 186

1.

Next-generation sequencing of translocation renal cell carcinoma reveals novel RNA splicing partners and frequent mutations of chromatin-remodeling genes.

Malouf GG, Su X, Yao H, Gao J, Xiong L, He Q, Compérat E, Couturier J, Molinié V, Escudier B, Camparo P, Doss DJ, Thompson EJ, Khayat D, Wood CG, Yu W, Teh BT, Weinstein J, Tannir NM.

Clin Cancer Res. 2014 Aug 1;20(15):4129-40. doi: 10.1158/1078-0432.CCR-13-3036. Epub 2014 Jun 4.

2.

Characterization of long non-coding RNA transcriptome in clear-cell renal cell carcinoma by next-generation deep sequencing.

Malouf GG, Zhang J, Yuan Y, Compérat E, Rouprêt M, Cussenot O, Chen Y, Thompson EJ, Tannir NM, Weinstein JN, Valero V, Khayat D, Spano JP, Su X.

Mol Oncol. 2015 Jan;9(1):32-43. doi: 10.1016/j.molonc.2014.07.007. Epub 2014 Jul 25.

3.

Identification of molecular tumor markers in renal cell carcinomas with TFE3 protein expression by RNA sequencing.

Pflueger D, Sboner A, Storz M, Roth J, Compérat E, Bruder E, Rubin MA, Schraml P, Moch H.

Neoplasia. 2013 Nov;15(11):1231-40.

4.

Genomic heterogeneity of translocation renal cell carcinoma.

Malouf GG, Monzon FA, Couturier J, Molinié V, Escudier B, Camparo P, Su X, Yao H, Tamboli P, Lopez-Terrada D, Picken M, Garcia M, Multani AS, Pathak S, Wood CG, Tannir NM.

Clin Cancer Res. 2013 Sep 1;19(17):4673-84. doi: 10.1158/1078-0432.CCR-12-3825. Epub 2013 Jul 1.

5.

CD31, EDNRB and TSPAN7 are promising prognostic markers in clear-cell renal cell carcinoma revealed by genome-wide expression analyses of primary tumors and metastases.

Wuttig D, Zastrow S, Füssel S, Toma MI, Meinhardt M, Kalman K, Junker K, Sanjmyatav J, Boll K, Hackermüller J, Rolle A, Grimm MO, Wirth MP.

Int J Cancer. 2012 Sep 1;131(5):E693-704. doi: 10.1002/ijc.27419. Epub 2012 Feb 28.

6.

Tumor-specific isoform switch of the fibroblast growth factor receptor 2 underlies the mesenchymal and malignant phenotypes of clear cell renal cell carcinomas.

Zhao Q, Caballero OL, Davis ID, Jonasch E, Tamboli P, Yung WK, Weinstein JN; Kenna Shaw for TCGA research network., Strausberg RL, Yao J.

Clin Cancer Res. 2013 May 1;19(9):2460-72. doi: 10.1158/1078-0432.CCR-12-3708. Epub 2013 Feb 26.

7.

Downregulation of OCLN and GAS1 in clear cell renal cell carcinoma.

Conceição AL, Da Silva CT, Badial RM, Valsechi MC, Stuqui B, Gonçalves JD, Jasiulionis MG, De Freitas Calmon M, Rahal P.

Oncol Rep. 2017 Mar;37(3):1487-1496. doi: 10.3892/or.2017.5414. Epub 2017 Jan 31.

PMID:
28184927
8.

Spectrum of diverse genomic alterations define non-clear cell renal carcinoma subtypes.

Durinck S, Stawiski EW, Pavía-Jiménez A, Modrusan Z, Kapur P, Jaiswal BS, Zhang N, Toffessi-Tcheuyap V, Nguyen TT, Pahuja KB, Chen YJ, Saleem S, Chaudhuri S, Heldens S, Jackson M, Peña-Llopis S, Guillory J, Toy K, Ha C, Harris CJ, Holloman E, Hill HM, Stinson J, Rivers CS, Janakiraman V, Wang W, Kinch LN, Grishin NV, Haverty PM, Chow B, Gehring JS, Reeder J, Pau G, Wu TD, Margulis V, Lotan Y, Sagalowsky A, Pedrosa I, de Sauvage FJ, Brugarolas J, Seshagiri S.

Nat Genet. 2015 Jan;47(1):13-21. doi: 10.1038/ng.3146. Epub 2014 Nov 17.

9.

PBRM1 Regulates the Expression of Genes Involved in Metabolism and Cell Adhesion in Renal Clear Cell Carcinoma.

Chowdhury B, Porter EG, Stewart JC, Ferreira CR, Schipma MJ, Dykhuizen EC.

PLoS One. 2016 Apr 21;11(4):e0153718. doi: 10.1371/journal.pone.0153718. eCollection 2016.

10.
11.

Molecular-genetic analysis is essential for accurate classification of renal carcinoma resembling Xp11.2 translocation carcinoma.

Hayes M, Peckova K, Martinek P, Hora M, Kalusova K, Straka L, Daum O, Kokoskova B, Rotterova P, Pivovarčikova K, Branzovsky J, Dubova M, Vesela P, Michal M, Hes O.

Virchows Arch. 2015 Mar;466(3):313-22. doi: 10.1007/s00428-014-1702-7. Epub 2014 Dec 28.

PMID:
25544614
12.

Wnt antagonist DKK1 acts as a tumor suppressor gene that induces apoptosis and inhibits proliferation in human renal cell carcinoma.

Hirata H, Hinoda Y, Nakajima K, Kawamoto K, Kikuno N, Ueno K, Yamamura S, Zaman MS, Khatri G, Chen Y, Saini S, Majid S, Deng G, Ishii N, Dahiya R.

Int J Cancer. 2011 Apr 15;128(8):1793-803. doi: 10.1002/ijc.25507.

13.

Dicer is down-regulated in clear cell renal cell carcinoma and in vitro Dicer knockdown enhances malignant phenotype transformation.

Ma X, Fan Y, Gao Y, Zhang Y, Huang Q, Ai Q, Ni D, Chen W, Zhang P, Song E, Wang B, Shi T, Zheng T, Zhang X.

Urol Oncol. 2014 Jan;32(1):46.e9-17. doi: 10.1016/j.urolonc.2013.06.011. Epub 2013 Oct 4.

PMID:
24094887
14.

The PTEN regulator DJ-1 is associated with hTERT expression in clear cell renal cell carcinoma.

Sitaram RT, Cairney CJ, Grabowski P, Keith WN, Hallberg B, Ljungberg B, Roos G.

Int J Cancer. 2009 Aug 15;125(4):783-90. doi: 10.1002/ijc.24335.

15.

High TXNDC5 expression predicts poor prognosis in renal cell carcinoma.

Mo R, Peng J, Xiao J, Ma J, Li W, Wang J, Ruan Y, Ma S, Hong Y, Wang C, Gao K, Fan J.

Tumour Biol. 2016 Jul;37(7):9797-806. doi: 10.1007/s13277-016-4891-7. Epub 2016 Jan 26.

PMID:
26810069
16.

Overexpression of reptin in renal cell carcinoma contributes to tumor malignancies and its inhibition triggers senescence of cancer cells.

Ren J, Li W, Liu H, Yan L, Jiao W, Li D, Tang Y, Gu G, Xu Z.

Urol Oncol. 2013 Oct;31(7):1358-66. doi: 10.1016/j.urolonc.2012.01.004. Epub 2012 Feb 17.

PMID:
22341977
17.

TMED6-COG8 is a novel molecular marker of TFE3 translocation renal cell carcinoma.

Xu Y, Rao Q, Xia Q, Shi S, Shi Q, Ma H, Lu Z, Chen H, Zhou X.

Int J Clin Exp Pathol. 2015 Mar 1;8(3):2690-9. eCollection 2015.

18.

Loss of type III transforming growth factor-beta receptor expression is due to methylation silencing of the transcription factor GATA3 in renal cell carcinoma.

Cooper SJ, Zou H, Legrand SN, Marlow LA, von Roemeling CA, Radisky DC, Wu KJ, Hempel N, Margulis V, Tun HW, Blobe GC, Wood CG, Copland JA.

Oncogene. 2010 May 20;29(20):2905-15. doi: 10.1038/onc.2010.64. Epub 2010 Mar 8.

19.

MYC pathway is activated in clear cell renal cell carcinoma and essential for proliferation of clear cell renal cell carcinoma cells.

Tang SW, Chang WH, Su YC, Chen YC, Lai YH, Wu PT, Hsu CI, Lin WC, Lai MK, Lin JY.

Cancer Lett. 2009 Jan 8;273(1):35-43. doi: 10.1016/j.canlet.2008.07.038. Epub 2008 Sep 21.

PMID:
18809243
20.

The chromatin remodeling gene ARID1A is a new prognostic marker in clear cell renal cell carcinoma.

Lichner Z, Scorilas A, White NM, Girgis AH, Rotstein L, Wiegand KC, Latif A, Chow C, Huntsman D, Yousef GM.

Am J Pathol. 2013 Apr;182(4):1163-70. doi: 10.1016/j.ajpath.2013.01.007. Epub 2013 Feb 12.

PMID:
23416164

Supplemental Content

Support Center